Efficacy of mitoxantrone-based salvage therapies in relapsed or refractory acute myeloid leukemia in the Mayo Clinic Cancer Center: Analysis of survival after ‘CLAG-M’ vs. ‘MEC’-Reference-Cited by-同舟云学术

Efficacy of mitoxantrone-based salvage therapies in relapsed or refractory acute myeloid leukemia in the Mayo Clinic Cancer Center: Analysis of survival after ‘CLAG-M’ vs. ‘MEC’

Published:2020-03 Issue: Volume:90 Page:106300
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Scheckel Caleb J^ORCID,Meyer Megan,Betcher Jeffrey Alan,Al-Kali Aref,Foran James,Palmer Jeanne

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference19 articles.

1. Cancer Facts and Figures,2018

2. Cancer Stat Facts: Acute Myeloid Leukemia,2018

3. Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis: a report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology Group;Rowe;Cancer,2010

4. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure;Duval;J. Clin. Oncol.,2010

5. Validation of the European Prognostic Index for younger adult patients with acute myeloid leukaemia in first relapse;Giles;Br. J. Haematol.,2006

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A hybrid protocol CLAG-M, a possible player for the first-line therapy of patients with mixed phenotype acute leukemia. A Polish Adult Leukemia Group experience;Frontiers in Oncology;2024-05-21

2. Impact of cladribine, cytarabine, and G-CSF (CLAG) as a bridging therapy prior to allogeneic hematopoietic stem cell transplantation in relapsed or refractory acute myeloid leukemia;Annals of Hematology;2024-05-17

3. Decitabine as epigenetic priming with CLAG induce improved outcome of relapsed or refractory acute myeloid leukemia in children;Clinical Epigenetics;2024-05-09

4. Efficacy and safety of mitoxantrone, etoposide, and cytarabine for treatment of relapsed or refractory acute myeloid leukemia;Leukemia Research;2024-04

5. Phase 1 study of selinexor in combination with salvage chemotherapy in Adults with relapsed or refractory Acute myeloid leukemia;Leukemia & Lymphoma;2023-09-04